Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer

NCT00651326 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

48

Enrollment

NETWORK

Sponsor class

Stopped Poor accrual

Conditions

Prostate Cancer

Interventions

DRUG: bicalutamide
DRUG: buserelin
DRUG: flutamide
DRUG: goserelin
DRUG: leuprolide acetate
PROCEDURE: neoadjuvant therapy
PROCEDURE: quality-of-life assessment
RADIATION: radiation therapy
DRUG: Docetaxel

Sponsor

NCIC Clinical Trials Group